---
layout: post
title: "韩国就辉瑞的口服新冠药物Paxlovid展开审查"
date: 2021-12-22 13:59:00 +0800
categories: emnews
tags: 东财滚动新闻
---
> 韩国就辉瑞的口服新冠药物Paxlovid展开审查。

<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=106.PFE&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" alt="K图 PFE_0" data-code="K PFE|106|7" data-code2="K PFE|106|1|" style="border:#d1d1d1 1px solid;" width="578" height="276" border="0" /></p><!-- EM_StockImg_End --><p>韩国就<span id="stock_106.PFE"><a href="http://quote.eastmoney.com/unify/r/106.PFE" class="keytip" data-code="106,PFE">辉瑞</a></span><span id="quote_106.PFE"></span>的口服新冠药物Paxlovid展开审查。 <br /></p><p class="em_media">（文章来源：财联社）</p>

<http://stock.eastmoney.com/news/11228,202112222222626925.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)